• Pepstatin A and the Next Frontier in Aspartic Protease In...

  2025-09-27

  Explore how Pepstatin A, a leading aspartic protease inhibitor, is reshaping biomedical research—from precise suppression of proteolytic activity to novel roles in viral and bone biology. This in-depth analysis uncovers mechanisms, comparative insights, and future directions beyond current literature.

• HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit: Enabling...

  2025-09-26

  Unlock the power of the HyperScribe T7 High Yield Cy3 RNA Labeling Kit for advanced in vitro transcription RNA labeling and quantitative fluorescent detection of gene expression. This article uniquely explores its impact on dissecting lncRNA regulatory networks and cellular signaling, surpassing conventional probe synthesis guides.

• TAK-242 (Resatorvid): Epigenetic Regulation and Microglia...

  2025-09-25

  Explore the unique epigenetic and transcriptional mechanisms by which TAK-242, a selective TLR4 inhibitor, suppresses neuroinflammation. This in-depth analysis highlights TAK-242’s innovative role in microglial polarization, offering new insights for neuropsychiatric and ischemic stroke research.

• WY-14643 (Pirinixic Acid): Precision Modulation of PPARα ...

  2025-09-24

  Explore the advanced role of WY-14643, a selective PPARα agonist, in reshaping the tumor microenvironment and enhancing insulin sensitivity. This article uniquely integrates multiomics insights and translational perspectives for metabolic disorder research.

• Bortezomib (PS-341): Dissecting Proteasome Inhibition and...

  2025-09-23

  Explore how Bortezomib (PS-341), a reversible proteasome inhibitor, is leveraged to study proteasome-regulated cellular processes and programmed cell death mechanisms, with novel insights into mitochondrial proteostasis. This article bridges cutting-edge findings in metabolism regulation with the strategic application of Bortezomib in cancer research.

• Protease Inhibitor Cocktail EDTA-Free: Advancing Proteome...

  2025-09-22

  Explore the critical applications of Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) for preserving protein integrity during extraction, with a focus on its role in studies of macrophage reprogramming, inflammasome activation, and chronic liver disease.

• Tamoxifen as a Research Tool: Novel Mechanistic Insights ...

  2025-09-19

  Explore the multifaceted roles of Tamoxifen as a selective estrogen receptor modulator, highlighting its emerging applications in gene knockout models, kinase inhibition, and antiviral research. This article provides technical insights and practical considerations for scientists utilizing Tamoxifen in advanced molecular and translational studies.

• TMCB: A Molecular Tool for Enzyme and Protein Phase Separ...

  2025-09-18

  Explore the utility of 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid as a biochemical reagent for protein interaction studies. This article provides a rigorous perspective on TMCB(CK2 and ERK8 inhibitor) as a benzimidazole-based small molecule inhibitor for advanced biochemical research.

• T4 DNA ligase molecular biology As one of emerging high thro

  2025-03-03

  

  As one of emerging high-throughout methods, metabolomics detects metabolites which are ultimate response of biological systems to environmental changes [14]. Metabolomics uncovers metabolic alteration at the systems level. Comparison of global metabolic profiling reflects some unidentified biologica

• AKT activity is also self limiting through

  2025-03-03

  

  AKT activity is also self-limiting through its substrate GSK3β; the kinase activity of which is negatively regulated by AKT phosphorylation (Fig. 3; Li, Liu, & Gao, 2009). GSK3β activation results in phosphorylation and subsequent ubiquitin mediated degradation of PHLPP (Li et al., 2009). AKT activa

• Last decade has provided a number

  2025-03-03

  

  Last decade has provided a number of studies indicating that AhR signaling could play a role both in the development and in progression of multiple cancer types, with potential implications for cancer therapy (for review see (Kolluri et al., 2017; Murray et al., 2014)). Activation of AhR is consider

• The direction of research then turned to investigating

  2025-03-03

  

  The direction of research then turned to investigating the long-term effects of adiponectin on insulin resistance. Adiponectin transgenic mice showed a reduction in insulin resistance and diabetes [5,6], while adiponectin-deficient mice showed mild insulin resistance with glucose intolerance, as wel

• Our in vitro data show that

  2025-03-03

  

  Our in vitro data show that CyaA does not play a critical role in the bacterial adherence to mammalian cells. This observation is in contrast to previous studies that reported a role for CyaA in FHA-mediated adherence of B. pertussis bacteria to the respiratory epithelial Cryptochlorogenic acid rece

• corticotropin-releasing factor br Adenosine receptors and th

  2025-03-03

  

  Adenosine receptors and the adaptive immunity T lymphocytes are responsible for the cell-mediated immune response [95]. These cells can be stimulated by the presentation of antigenic moieties by APCs, such as dendritic cells or macrophages [96]. The presentation of antigenic molecules on the APC

• As an alternative to chronic receptor blockade we

  2025-03-03

  

  As an alternative to chronic receptor blockade, we have been targeting adenosine kinase (ADK) – an astrocyte-based enzyme that catalyses the phosphorylation of adenosine, as a means to modify dihydromyricetin benefits adenosinergic signalling (Boison, 2006, Etherington et al., 2009). Up-regulating

15658 records 1/1044 page Next 12345 下5页 Last page